The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CD45-positive tumor infiltrating lymphocytes in early-stage hormone-positive, HER2-negative (ER+/HER2-) breast cancer: Correlation with proliferation and prognostic signature scores.
 
Mairi Lucas
Honoraria - Stada
 
Zak Kinsella
No Relationships to Disclose
 
Claudia Aura Gonzalez
No Relationships to Disclose
 
Camille Hurley
No Relationships to Disclose
 
Anna Blümel
No Relationships to Disclose
 
Joanna Fay
No Relationships to Disclose
 
Anthony O'Grady
No Relationships to Disclose
 
Verena Murphy
No Relationships to Disclose
 
Chowdhury Arif Jahangir
No Relationships to Disclose
 
Caoimbhe Burke
No Relationships to Disclose
 
Arman Rahman
No Relationships to Disclose
 
John Crown
Employment - OncoAssure; OncoMark
Stock and Other Ownership Interests - OncoAssure; OncoMark
Honoraria - MSD Oncology; Novartis Ireland Ltd.; Pfizer; Roche
Consulting or Advisory Role - G1 Therapeutics; MSD Oncology; Novartis Ireland Ltd.; Pfizer; Puma Biotechnology; Roche
Speakers' Bureau - Pfizer
Research Funding - Boehringer Ingelheim (Inst); Eisai (Inst); Puma Biotechnology (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - WO2020011770 (A1) - A method of predicting response to treatment in cancer patients
Travel, Accommodations, Expenses - Abbvie; Daiichi Sankyo Europe GmbH; MSD; Novartis Ireland Ltd.; Pfizer; Roche
 
Catherine Margaret Kelly
Honoraria - Pfizer; Roche Ireland
 
William M. Gallagher
Employment - OncoAssure; OncoMark
Leadership - OncoAssure; OncoMark
Stock and Other Ownership Interests - OncoAssure; OncoMark
Patents, Royalties, Other Intellectual Property - OncoAssure; OncoMark
 
Darran O'Connor
No Relationships to Disclose